2. Part I of the First Schedule to the Misuse of Drugs Act is amended —| (a) | by deleting items (21), (38), (49), (62), (84) and (127) of paragraph 1; | | (b) | by deleting item (1) of paragraph 7 and substituting the following items:| “(1) | Acetylfentanyl (also known as desmethyl fentanyl) | | (1A) | Alfentanil”; |
|
| | (c) | by inserting, immediately after item (12) of paragraph 7, the following item: | | (d) | by deleting items (2A) and (2B) of paragraph 18 and substituting the following items:| “(2A) | 2-Amino-1-(4-bromo-2,5-dimethoxyphenyl)ethan-1-one (also known as bk-2C-B) and its bromo and dimethoxy positional isomers in the phenyl ring | | (2B) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (also known as MAB-CHMINACA) | | (2C) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (also known as 5-Fluoro-ADB-PINACA) and its fluoro positional isomers in the pentyl group | | (2D) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (also known as ADB-PINACA) | | (2E) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-chloropentyl)-1H-indazole-3-carboxamide (also known as 5-Chloro-AB-PINACA) and its chloro positional isomers in the pentyl group | | (2F) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (also known as AB-CHMINACA) | | (2G) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (also known as AB-FUBINACA) and its fluoro positional isomers in the phenyl ring | | (2H) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (also known as 5-Fluoro-AB-PINACA) and its fluoro positional isomers in the pentyl group | | (2I) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (also known as AB-PINACA) | | (2J) | N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (also known as PX-2) and its fluoro positional isomers in the pentyl group | | (2K) | N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (also known as PX-1) and its fluoro positional isomers in the pentyl group | | (2L) | 4-(2-Aminopropyl)benzofuran (also known as 4-APB)”; |
|
| | (e) | by inserting, immediately after item (6A) of paragraph 18, the following item:| “(6AA) | 1-(1-Benzofuran-5-yl)-N-ethylpropan-2-amine (also known as 5-EAPB) and its 4-yl, 6-yl and 7-yl isomers”; |
|
| | (f) | by inserting, immediately after item (8A) of paragraph 18, the following item:| “(8B) | 1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (also known as MT-45)”; |
|
| | (g) | by inserting, immediately after item (15A) of paragraph 18, the following item:| “(15B) | 2-(2,5-Dimethoxyphenyl)ethanamine (also known as 2C-H) and its dimethoxy positional isomers in the phenyl ring”; |
|
| | (h) | by inserting, immediately after item (19) of paragraph 18, the following items:| “(19A) | Ethylphenidate | | (19B) | [1-(5-Fluoropent-1-yl)-1H-benzimidazol-2-yl](naphthalen-1-yl)methanone (also known as FUBIMINA) and its fluoro positional isomers in the pentyl group | | (19C) | [1-(5-Fluoropent-1-yl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (also known as THJ-2201) and its fluoro positional isomers in the pentyl group”; |
|
| | (i) | by deleting item (27A) of paragraph 18 and substituting the following items:| “(27A) | 1-(1H-Indol-5-yl)propan-2-amine (also known as 5-IT) and its 4-yl, 6-yl and 7-yl isomers | | (27B) | 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25I-NBOMe) | | (27C) | 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (also known as 2C-I) and its dimethoxy and iodo positional isomers in the phenyl ring”; |
|
| | (j) | by inserting, immediately after item (28) of paragraph 18, the following items:| “(28A) | Methyl 2-[1-(cyclohexylmethyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (also known as MDMB-CHMINACA) | | (28B) | Methyl 2-[1-(cyclohexylmethyl)-1H-indazole-3-carboxamido]-3-methylbutanoate (also known as MA-CHMINACA) | | (28C) | Methyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3-methylbutanoate (also known as 5-Fluoro-AMB) and its fluoro positional isomers in the pentyl group”; |
|
| | (k) | by inserting, immediately after item (30) of paragraph 18, the following item:| “(30A) | 4-Methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine (also known as 4,4’-Dimethylaminorex, 4,4’-DMAR or para-methyl-4-methylaminorex) and its methyl positional isomers in the phenyl ring”; |
|
| | (l) | by deleting item (33) of paragraph 18 and substituting the following item:| “(33) | N-Methyl-1-(thiophen-2-yl)propan-2-amine (also known as methiopropamine) and its thiophen-3-yl isomer”; and |
|
| | (m) | by inserting, immediately after paragraph 18, the following paragraph:“19. Any compound (other than serotonin) structurally derived from 2-(1H-indol-3-yl)ethanamine (also known as tryptamine) by modification in any of the following ways:| (a) | substitution at the nitrogen atom of the side chain to any extent with alkyl or alkenyl substituents, or by inclusion of only the nitrogen atom of the side chain in a cyclic structure; | | (b) | substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents; | | (c) | substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, hydroxy, thioalkyl, alkylenedioxy, halide or acetoxy substituents; | | (d) | substitution at the 2-position of the tryptamine ring system with an alkyl substituent, |
| including any ether, salt or stereoisomeric form of any such compound, any preparation or product containing any such compound, and the following examples of such a compound: |
| (1) | 4-Acetoxy-N,N-diisopropyltryptamine (also known as 4-Acetoxy-DiPT or 4-AcO-DiPT) | | (2) | 4-Acetoxy-N,N-dimethyltryptamine (also known as 4-Acetoxy-DMT or 4-AcO-DMT) | | (3) | 5-Benzyloxytryptamine | | (4) | 5-Bromo-N,N-dimethyltryptamine (also known as 5-Bromo-DMT) | | (5) | 5-Bromotryptamine | | (6) | 5-Chloro-α-methyltryptamine (also known as 5-Chloro-AMT) | | (7) | 5-Chlorotryptamine | | (8) | N,N-Diallyltryptamine | | (9) | N,N-Diethyltryptamine | | (10) | N,N-Diisopropyltryptamine | | (11) | N,N-Dimethyltryptamine | | (12) | N,N-Dipropyltryptamine | | (13) | Etryptamine | | (14) | 5-Fluoro-N,N-dimethyltryptamine (also known as 5-Fluoro-DMT) | | (15) | 5-Fluoro-α-methyltryptamine (also known as 5-Fluoro-AMT) | | (16) | 5-Fluorotryptamine | | (17) | 4-Hydroxy-N,N-diethyltryptamine (also known as 4-Hydroxy-DET or 4-HO-DET) | | (18) | 4-Hydroxy-N,N-diisopropyltryptamine (also known as 4-Hydroxy-DiPT or 4-HO-DiPT) | | (19) | 4-Hydroxy-N,N-dimethyltryptamine (also known as Psilocin) | | (20) | 4-Hydroxy-N-methyl-N-ethyltryptamine (also known as 4-Hydroxy-MET or 4-HO-MET) | | (21) | 4-Hydroxy-N-methyl-N-isopropyltryptamine (also known as 4-Hydroxy-MiPT or 4-HO-MiPT) | | (22) | 4-Hydroxy-α-methyltryptamine (also known as 4-Hydroxy-AMT or 4-HO-AMT) | | (23) | 5-Hydroxy-N-methyltryptamine (also known as 5-Hydroxy-NMT or 5-HO-NMT) | | (24) | 5-Hydroxy-N,N-dimethyltryptamine (also known as Bufotenine) | | (25) | 5-Methoxy-N,N-diallyltryptamine (also known as 5-Methoxy-DALT or 5-MeO-DALT) | | (26) | 5-Methoxy-N,N-diethyltryptamine (also known as 5-Methoxy-DET or 5-MeO-DET) | | (27) | 5-Methoxy-N,N-diisopropyltryptamine (also known as 5-Methoxy-DiPT or 5-MeO-DiPT) | | (28) | 5-Methoxy-N,N-dimethyltryptamine (also known as 5-Methoxy-DMT or 5-MeO-DMT) | | (29) | 5-Methoxy-N,N-dipropyltryptamine (also known as 5-Methoxy-DPT or 5-MeO-DPT) | | (30) | 5-Methoxy-N-ethyl-N-isopropyltryptamine (also known as 5-Methoxy-EiPT or 5-MeO-EiPT) | | (31) | 5-Methoxy-N-ethyl-N-propyltryptamine (also known as 5-Methoxy-EPT or 5-MeO-EPT) | | (32) | 5-Methoxy-α-ethyltryptamine (also known as 5-Methoxy-AET or 5-MeO-AET) | | (33) | 5-Methoxy-N-methyl-N-isopropyltryptamine (also known as 5-Methoxy-MiPT or 5-MeO-MiPT) | | (34) | 5-Methoxy-α-methyltryptamine (also known as 5-Methoxy-AMT or 5-MeO-AMT) | | (35) | 5-Methoxy-N-methyltryptamine (also known as 5-Methoxy-NMT or 5-MeO-NMT) | | (36) | 4-Methyl-α-ethyltryptamine (also known as 4-Methyl-AET) | | (37) | 5-Methyltryptamine | | (38) | α-Methyltryptamine | | (39) | N-Methyltryptamine”. |
|
|
|
|
